These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 11496955

  • 1. Effect of mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds.
    Dagenais C, Zong J, Ducharme J, Pollack GM.
    Pharm Res; 2001 Jul; 18(7):957-63. PubMed ID: 11496955
    [Abstract] [Full Text] [Related]

  • 2. Variable modulation of opioid brain uptake by P-glycoprotein in mice.
    Dagenais C, Graff CL, Pollack GM.
    Biochem Pharmacol; 2004 Jan 15; 67(2):269-76. PubMed ID: 14698039
    [Abstract] [Full Text] [Related]

  • 3. Modulation of P-glycoprotein transport activity in the mouse blood-brain barrier by rifampin.
    Zong J, Pollack GM.
    J Pharmacol Exp Ther; 2003 Aug 15; 306(2):556-62. PubMed ID: 12721332
    [Abstract] [Full Text] [Related]

  • 4. Impact of P-glycoprotein on blood-retinal barrier permeability: comparison of blood-aqueous humor and blood-brain barrier using mdr1a knockout rats.
    Fujii S, Setoguchi C, Kawazu K, Hosoya K.
    Invest Ophthalmol Vis Sci; 2014 Jul 01; 55(7):4650-8. PubMed ID: 24985475
    [Abstract] [Full Text] [Related]

  • 5. In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrier.
    Cisternino S, Rousselle C, Debray M, Scherrmann JM.
    Pharm Res; 2004 Aug 01; 21(8):1382-9. PubMed ID: 15359572
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate.
    Kodaira H, Kusuhara H, Fujita T, Ushiki J, Fuse E, Sugiyama Y.
    J Pharmacol Exp Ther; 2011 Dec 01; 339(3):935-44. PubMed ID: 21934030
    [Abstract] [Full Text] [Related]

  • 8. Interaction of nonpeptidic delta agonists with P-glycoprotein by in situ mouse brain perfusion: liquid chromatography-mass spectrometry analysis and internal standard strategy.
    Dagenais C, Ducharme J, Pollack GM.
    J Pharm Sci; 2002 Jan 01; 91(1):244-52. PubMed ID: 11782913
    [Abstract] [Full Text] [Related]

  • 9. Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone.
    Kodaira H, Kusuhara H, Ushiki J, Fuse E, Sugiyama Y.
    J Pharmacol Exp Ther; 2010 Jun 01; 333(3):788-96. PubMed ID: 20304939
    [Abstract] [Full Text] [Related]

  • 10. Morphine antinociception is enhanced in mdr1a gene-deficient mice.
    Zong J, Pollack GM.
    Pharm Res; 2000 Jun 01; 17(6):749-53. PubMed ID: 10955852
    [Abstract] [Full Text] [Related]

  • 11. Regional differences in capillary density, perfusion rate, and P-glycoprotein activity: a quantitative analysis of regional drug exposure in the brain.
    Zhao R, Pollack GM.
    Biochem Pharmacol; 2009 Oct 15; 78(8):1052-9. PubMed ID: 19523457
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier.
    Bourasset F, Cisternino S, Temsamani J, Scherrmann JM.
    J Neurochem; 2003 Sep 15; 86(6):1564-7. PubMed ID: 12950465
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antinociceptive effects of morphine-6-glucuronide in homozygous MDR1a P-glycoprotein knockout and in wildtype mice in the hotplate test.
    Lötsch J, Tegeder I, Angst MS, Geisslinger G.
    Life Sci; 2000 May 05; 66(24):2393-403. PubMed ID: 10864101
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Contribution of P-glycoprotein to bunitrolol efflux across blood-brain barrier.
    Matsuzaki J, Yamamoto C, Miyama T, Takanaga H, Matsuo H, Ishizuka H, Kawahara Y, Kuwano M, Naito M, Tsuruo T, Sawada Y.
    Biopharm Drug Dispos; 1999 Mar 05; 20(2):85-90. PubMed ID: 10206323
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.